D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFXA
501
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $32.7M | 0.04% |
+245,000
| New | +$29.7M |
|
|
KL
502
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $32.4M | 0.04% |
1,063,779
+81,499
| +8% | +$2.58M |
|
503
Navient
NAVI
$774M
| $32.3M | 0.04% |
2,791,886
-1,254,582
| -31% | -$14.4M |
|
504
United Therapeutics
UTHR
$26.3B
| $32.3M | 0.04% |
275,073
-162,003
| -37% | -$18.9M |
|
|
SEE
505
DELISTED
Sealed Air
SEE
| $32.2M | 0.04% |
698,039
-286,187
| -29% | -$11.9M |
|
506
TC Energy
TRP
$73.5B
| $32.1M | 0.04% |
714,913
-1,102,020
| -61% | -$47.4M |
|
|
EVBG
507
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $32.1M | 0.04% |
427,930
+352,902
| +470% | +$23M |
|
|
DYNC
508
DELISTED
Vistra Energy Corp.
DYNC
| $32.1M | 0.04% |
+325,000
| New | +$31.6M |
|
509
Evergy
EVRG
$20.1B
| $32M | 0.04% |
550,941
-110,751
| -17% | -$6.3M |
|
|
ZEN
510
DELISTED
ZENDESK INC
ZEN
| $31.8M | 0.04% |
374,592
-164,927
| -31% | -$12.1M |
|
511
Autodesk
ADSK
$44.3B
| $31.7M | 0.04% |
203,174
+4,050
| +2% | +$605K |
|
512
NovoCure
NVCR
$2.04B
| $31.6M | 0.04% |
656,881
+614,012
| +1,432% | +$29.6M |
|
|
THS
513
DELISTED
Treehouse Foods
THS
| $31.6M | 0.04% |
489,375
+179,057
| +58% | +$10.6M |
|
514
BHP
BHP
$213B
| $31.4M | 0.04% |
644,381
-822,148
| -56% | -$37.5M |
|
|
MNTA
515
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.2M | 0.04% |
2,148,849
-449,793
| -17% | -$5.74M |
|
|
CATM
516
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $31.2M | 0.04% |
876,174
+174,919
| +25% | +$5.21M |
|
517
DNOW Inc
DNOW
$2.63B
| $31.1M | 0.04% |
2,226,959
-42,164
| -2% | -$586K |
|
518
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $31M | 0.04% |
+358,998
| New | +$30.5M |
|
519
Fox Class A
FOXA
$23.2B
| $31M | 0.04% |
+845,467
| New | +$32.9M |
|
520
PUT
Lam Research
LRCX
$382B
| $30.8M | 0.04% |
1,719,000
-2,017,000
| -54% | -$33.7M |
|
|
MASI
521
DELISTED
Masimo
MASI
| $30.7M | 0.04% |
222,248
-55,741
| -20% | -$7M |
|
|
ZIONW
522
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $30.6M | 0.04% |
2,308,700
| – | – |
|
523
HubSpot
HUBS
$10.5B
| $30.6M | 0.04% |
183,809
+150,623
| +454% | +$23.9M |
|
524
NextEra Energy
NEE
$187B
| $30.5M | 0.04% |
630,760
-345,080
| -35% | -$15.8M |
|
525
Ascendis Pharma A/S
ASND
$16.7B
| $30.4M | 0.04% |
258,177
+211,996
| +459% | +$18.6M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.